We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+5.95%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$7.75B
AUM Growth
+$180M
Cap. Flow
-$55.1M
Cap. Flow %
-0.71%
Top 10 Hldgs %
15.53%
Holding
560
New
192
Increased
91
Reduced
96
Closed
133

Top Buys

Rank Stock Value
1
UBER icon
Uber
UBER
+$122M
2
LHX icon
L3Harris
LHX
+$117M
3
GD icon
General Dynamics
GD
+$110M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$103M
5
NXPI icon
NXP Semiconductors
NXPI
+$91M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$143M
2
LLL
L3 Technologies, Inc.
LLL
+$111M
3
SWKS icon
Skyworks Solutions
SWKS
+$109M
4
LOW icon
Lowe's Companies
LOW
+$93.7M
5
EMR icon
Emerson Electric
EMR
+$88.8M

Sector Composition

Rank Sector Weight
1 Technology 21.47%
2 Industrials 15.13%
3 Healthcare 14.64%
4 Financials 8.83%
5 Consumer Discretionary 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMDX icon
376
Transmedics
TMDX
$2.91B
$864K 0.01%
+29,807
New +$814K
NVT icon
377
nVent Electric
NVT
$26.7B
$857K 0.01%
+34,571
New +$890K
ESTR
378
CALL
DELISTED
Estre Ambiental, Inc.
ESTR
$855K 0.01%
945,134
– –
ALGN icon
379
Align Technology
ALGN
$12.3B
$814K 0.01%
2,975
-69,744
-96% -$21.1M
RNR icon
380
RenaissanceRe
RNR
$13.4B
$813K 0.01%
+4,569
New +$751K
TRVI icon
381
Trevi Therapeutics
TRVI
$2.64B
$751K 0.01%
+100,119
New +$862K
XFOR icon
382
CALL
X4 Pharmaceuticals
XFOR
$460M
$750K 0.01%
+1,667
New +$847K
ZVRA icon
383
Zevra Therapeutics
ZVRA
$686M
$748K 0.01%
26,721
-67,207
-72% -$1.69M
FSTX
384
CALL
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$738K 0.01%
50,000
– –
ODT
385
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$734K 0.01%
+20,009
New +$479K
HHR
386
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$725K 0.01%
+44,591
New +$731K
RITM icon
387
Rithm Capital
RITM
$5.69B
$721K 0.01%
+46,859
New +$764K
AXLA
388
DELISTED
Axcella Health Inc. Common Stock
AXLA
$708K 0.01%
+3,042
New +$964K
VRTX icon
389
Vertex Pharmaceuticals
VRTX
$126B
$699K 0.01%
+3,811
New +$666K
BLK icon
390
Blackrock
BLK
$176B
$672K 0.01%
+1,432
New +$648K
APVO icon
391
CALL
Aptevo Therapeutics
APVO
$5.21M
– –
0
– –
EVFM
392
CALL
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$664K 0.01%
6,667
– –
TROW icon
393
T. Rowe Price
TROW
$24.3B
$655K 0.01%
+5,974
New +$628K
AJG icon
394
Arthur J. Gallagher & Co
AJG
$63.6B
$639K 0.01%
7,290
-14,062
-66% -$1.17M
BFH icon
395
Bread Financial
BFH
$4.38B
$627K 0.01%
+5,608
New +$678K
STKL
396
DELISTED
SunOpta
STKL
$614K 0.01%
186,587
-179,394
-49% -$661K
MBIO icon
397
Mustang Bio
MBIO
$4.55M
$610K 0.01%
+221
New +$631K
KBH icon
398
KB Home
KBH
$3.59B
$550K 0.01%
+21,390
New +$551K
ANET icon
399
Arista Networks
ANET
$238B
$548K 0.01%
+33,744
New +$584K
GSK icon
400
GSK
GSK
$106B
$541K 0.01%
+10,811
New +$542K
14 15
16
17 18

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2019 Portfolio in Review

As of Q2 2019, Alyeska Investment Group held 560 positions worth $7.75B, up 2.4% from $7.57B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group's Q2 2019 filing shows 192 new, 91 increased, 96 reduced and 133 closed positions. Its largest new stake was Uber: 2,870,924 shares worth $133M. The largest sale was Intel, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Alyeska Investment Group's largest Q2 2019 buy was Uber: 2,870,924 shares worth $133M.
  • Alyeska Investment Group added most to NXP Semiconductors in Q2 2019, an estimated $91M increase.
  • Alyeska Investment Group's biggest Q2 2019 reduction was Activision Blizzard, cutting an estimated $64.8M.
  • Alyeska Investment Group fully exited Intel in Q2 2019, selling an estimated $143M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $7.75B portfolio in Q2 2019.
  • Alyeska Investment Group opened 192 new positions and closed 133 in Q2 2019.
  • Alyeska Investment Group's portfolio value rose 2.4% quarter-over-quarter to $7.75B.

Based on Alyeska Investment Group's 13F filing for Q2 2019, filed 14 Aug 2019.